Live feed08:45:00·2hPRReleasevia QuantisnowVivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia TestByQuantisnow·Wall Street's wire, on your screen.VVOS· Vivos Therapeutics Inc.Health Care
